Tuesday, Oct 20, 2020 | Last Update : 07:45 PM IST

195th Day Of Lockdown

Maharashtra1443409114960338084 Andhra Pradesh7192566588755981 Karnataka6406615157829286 Tamil Nadu6088555529389653 Uttar Pradesh4031013468595864 Delhi2827522506135401 West Bengal2603242287555017 Odisha222734190080912 Kerala204242131048772 Telangana1992761701091163 Bihar178882164537888 Assam169985139977655 Gujarat1332191132403417 Rajasthan1288591077181441 Haryana1237821059901307 Madhya Pradesh117588932382207 Punjab107096840253134 Chhatisgarh9856566860777 Jharkhand7770964515661 Jammu and Kashmir69832495571105 Uttarakhand4533233642555 Goa3107125071386 Puducherry2548919781494 Tripura2412717464262 Himachal Pradesh136799526152 Chandigarh112128677145 Manipur9791760263 Arunachal Pradesh8649623014 Nagaland5768469311 Meghalaya5158334343 Sikkim2707199431 Mizoram178612880
  Life   Health  15 Aug 2018  Here's how stress hormone prevents Leukemia

Here's how stress hormone prevents Leukemia

ANI
Published : Aug 15, 2018, 6:34 pm IST
Updated : Aug 15, 2018, 6:34 pm IST

This explains why the immune system fails to prevent leukemia from taking hold.

Cancer cells evade the anti-cancer activity of the human immune system by employing the human hormone cortisol.  (Photo: Pixabay)
 Cancer cells evade the anti-cancer activity of the human immune system by employing the human hormone cortisol. (Photo: Pixabay)

A human stress hormone called cortisol has been identified by scientists as a key factor behind when and why the immune system fails to prevent leukemia from taking hold.

The team led by Dr. Vadim Sumbayev, of the University's Medway School of Pharmacy, found for the first time that blood or bone marrow cancer - acute myeloid leukemia (AML) - cells evade the anti-cancer activity of the human immune system by employing the human hormone cortisol.

 

The study of the causes of AML - the most severe blood or bone marrow cancer, demonstrated that AML cells employ a unique pathway for the disease to progress, using functional systems of the human body to both support their survival and also reduce the anticancer activities of immune cells.

They do this by using cortisol to force the release of a protein, latrophilin 1. 

This, in turn, causes the secretion of another protein, galectin-9, which suppresses the body's natural anti-cancer immune mechanism.

Dr. Sumbayev's team, working with researchers from two German universities and the UK's Diamond Light Source facility, found that although healthy human white blood cells are not affected by cortisol, they become capable of releasing latrophilin 1 when the malignant transformation takes place.

 

Malignant AML cells then use cortisol to increase the release of latrophilin 1 so that they can use it to avoid the immune system.

Dr. Sumbayev said, "For the first time, we can identify a possible future pathway to develop an effective new therapy using the body's natural immune mechanisms. We have discovered a new fundamental biochemical mechanism within the human body that allows AML cells to employ physiological systems to survive and escape immune attack."

The study concluded that galectin-9, as well as a natural binding partner of latrophilin 1 - known as FLRT3 - which are both present in human blood plasma, are the most promising targets for future anti-AML immune therapy.

 

The full findings are present in the journal- Cellular and Molecular Immunology.

Tags: stress hormone, cortisol, cancer, leukemia